GGrantIndex
← Leaderboards

Joseph S Hanna

Case Western Reserve University

$133,691
Attributed
$133,691
Total exposure
11
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $30.3K · FY200506
$50K$37.5K$25K$12.5K$0
'05
'06

Funding mix

By agency

NIH$133,691 · 11

By mechanism

M01$133,691 · 11

Top collaborators

No co-investigators on record.

Most similar at Case Western Reserve University

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchHuman SubjectHuman Therapy EvaluationStrokeDrug Screening /EvaluationCardiovascular Disorder ChemotherapyAcute Disease /DisorderCerebral Ischemia /HypoxiaStroke TherapyPatient Oriented ResearchDrug Adverse EffectVitamin B12FolateRelapse /RecurrenceHomocysteineVitamin TherapyVitamin B6Cardiovascular Disorder PreventionMyocardial InfarctionNutrition Related TagPharmacokineticsGlycineCardiovascular AgentsBrain Disorder Chemotherapy

Grant awards (20)

SECONDARY PREVENTION OF SMALL SUBCORTICAL STROKES (SPS3)$16,493
M01 · FY2006 · RR · contact PI
WARFARIN VS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION$13,744
M01 · FY2006 · RR · contact PI
IV INFUSION OF ONO-2506 IN PATIENTS WITH ACUTE ISCHEMIC STROKE$82
M01 · FY2006 · RR · contact PI
WARFARIN VS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION$7,409
M01 · FY2005 · RR
Warfarin vs aspirin for symptomatic intracranial disease (WASID)$35,676
M01 · FY2004 · RR
Vitamin intervention for stroke prevention (VISP)$10,650
M01 · FY2004 · RR
Warfarin vs. aspirin in reduced cardiac ejection fraction$7,345
M01 · FY2004 · RR
Secondary prevention of small subcortical strokes (SPS3)$2,570
M01 · FY2004 · RR
IV Infusion of ONO-2506 in patients with acute ischemic stroke$606
M01 · FY2004 · RR
FK506 Lipid complex (LCG) in patients with recent ischemic stroke$553
M01 · FY2004 · RR
IV Repinotan HCL in patients with acute ischemic stroke$165
M01 · FY2004 · RR
GV150526 IN TREATMENT OF ACUTE STROKE$0
M01 · FY2002 · RR
CITICOLINE ON CLINICAL OUTCOME &EVOLUTION OF LESION VOLUME IN STROKE$0
M01 · FY2002 · RR
Vitamin intervention for stroke prevention$0
M01 · FY2002 · RR
Vitamin intervention for stroke prevention$0
M01 · FY2001 · RR
CITICOLINE ON CLINICAL OUTCOME &EVOLUTION OF LESION VOLUME IN STROKE$0
M01 · FY2001 · RR
GV150526 IN TREATMENT OF ACUTE STROKE$0
M01 · FY2001 · RR
GV150526 IN TREATMENT OF ACUTE STROKE$19,199
M01 · FY2000 · RR
CITICOLINE ON CLINICAL OUTCOME &EVOLUTION OF LESION VOLUME IN STROKE$19,199
M01 · FY2000 · RR
Vitamin intervention for stroke prevention$0
M01 · FY2000 · RR